Trial intelligence / Profile preview

Roxadustat dosing regimens in Chinese dialysis CKD anemia patients

CTR20190601Phase 4Completed

Sponsor
FaboGene
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of roxadustat in anaemia, sponsored by FaboGene. Started Mar 2019; status: completed.

02

Drugs

roxadustat
03

Conditions

anaemia

Beyond the preview

Go deeper on CTR20190601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call